Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | ClH.H3NO |
| Molecular Weight | 69.491 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NO
InChI
InChIKey=WTDHULULXKLSOZ-UHFFFAOYSA-N
InChI=1S/ClH.H3NO/c;1-2/h1H;2H,1H2
| Molecular Formula | H3NO |
| Molecular Weight | 33.0299 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity. | 2013-02-25 |
|
| Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. | 2012-08-20 |
|
| Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast. | 2011-06 |
|
| In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. | 2009-09 |
|
| Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. | 2006-05 |
|
| Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. | 2005-07 |
|
| NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. | 2004-12 |
|
| Developmental differences in the immortalization of lung fibroblasts by telomerase. | 2003-10 |
|
| N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. | 2001-10 |
|
| Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. | 2000-04 |
|
| Paraquat induces different pulmonary biochemical responses in Wistar rats and Swiss mice. | 2000-03-01 |
|
| The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives. | 1999-11-01 |
|
| Nitric oxide ameliorates actinomycin D/endotoxin-induced apoptotic liver failure in mice. | 1999-08 |
|
| Gas chromatographic-mass spectrometric analysis of hydroxylamine for monitoring the metabolic hydrolysis of metalloprotease inhibitors in rat and human liver microsomes. | 1999-03-05 |
|
| Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. | 1997-08 |
|
| Stratum corneum intercellular lipid as compared to erythrocyte ghosts: an ESR study of thermotropic behavior and nitroxide reduction. Electron Spin Resonance. | 1995 |
|
| Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. | 1993-11 |
|
| Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. | 1993-10-19 |
|
| Nitroxide radical biostability in skin. | 1993-10 |
|
| Sulfamethoxazole is metabolized to the hydroxylamine in humans. | 1992-05 |
|
| Acute neurotoxicity of sodium azide and nitric oxide. | 1991-07 |
|
| Availability of dinitrophenylated lipid haptens for specific antibody binding depends on the physical properties of host bilayer membranes. | 1982-06-10 |
|
| Central effects of endogenous and exogenous GABA. | 1978-05-01 |
|
| Effect of inactivation by hydroxylamine on early functions of poliovirus. | 1971-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:55:17 GMT 2025
by
admin
on
Mon Mar 31 19:55:17 GMT 2025
|
| Record UNII |
5X4ZA62Z4Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HYDROXYLAMMONIUM CHLORIDE
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
443297
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
5470-11-1
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
m6137
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | Merck Index | ||
|
5X4ZA62Z4Q
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
26250
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
226-798-2
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY | |||
|
DTXSID7025425
Created by
admin on Mon Mar 31 19:55:17 GMT 2025 , Edited by admin on Mon Mar 31 19:55:17 GMT 2025
|
PRIMARY |